STEFANIE KINCEY: Open Payments
NPI 1033517719 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$373 in 12 payments from 6 companies in 2025. Trend: 2023 $266 · 2024 $566 · 2025 $373
Food & beverage: $371Education: $2
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 6 | $146 |
| Lilly USA, LLC | 1 | $115 |
| Novartis Pharmaceuticals Corporation | 2 | $63 |
| AKEBIA THERAPEUTICS INC | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Travere Therapeutics, Inc. | 1 | $2 |
Products named: VELPHORO, Fabhalta, Auryxia, Kerendia, Filspari.
Industry payments across AL — which companies pay providers there.
